
Please try another search
Investing.com -- The Food and Drug Administration (FDA) has granted orphan drug designation to Rilzabrutinib, a drug developed by Sanofi (NASDAQ:SNY) SA (EPA:SAN) for the treatment of sickle cell...
Investing.com -- Moody's Ratings has upgraded the long-term issuer rating and senior unsecured ratings of Sanofi (NASDAQ:SNY) from A1 to Aa3. The outlook for the company has been revised from...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review